The promise of mRNA technology seemed boundless after the success of the coronavirus vaccines, but Robert F. Kennedy Jr. has singled it out for scrutiny, clouding its prospects.

The S&P 500’s biggest gainer was Moderna Inc (BMV: MRNA) up more than 9% after leading medical organizations filed a lawsuit ...

U.S. President Donald Trump's nominee for director of the CDC was pulled into political contention over U.S. vaccine policy ...

The Trump administration's cancellation of $766 million in contracts to develop mRNA vaccines against potential pandemic flu viruses is the latest blow to national defense, former health security ...

The S&P 500 fell 0.1% on Tuesday, July 8, 2025, after President Trump extended the deadline for "reciprocal" tariffs and ...

Three simultaneous withdrawals—from the World Health Organization, USAID and the Gavi vaccine alliance—represent a ...

For decades, one of the world’s most contagious diseases was considered eradicated in the U.S. But now measles is roaring ...

Republican Sen. Bill Cassidy of Louisiana has shared his concerns about Health Secretary Robert F. Kennedy Jr.’s picks for a vaccine advisory panel, arguing that the committee’s next meeting should be ...